Xiaoyan Liu

Also affiliated with Shanxi Medical University, Anhui Medical University, Chinese Academy of Sciences, Hefei Institutes of Physical Science, Anhui Institute of Optics and Fine Mechanics, National Science Centre, Statistical Research (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “970TiP SKYSCRAPER-05: Phase II study of neoadjuvant atezolizumab (Atezo) + tiragolumab (Tira) with or without platinum-based chemotherapy (CT) in patients (Pts) with locally advanced resectable stage II‒IIIB NSCLC”.

970TiP SKYSCRAPER-05: Phase II study of neoadjuvant atezolizumab (Atezo) + tiragolumab (Tira) with or without platinum-based chemotherapy (CT) in patients (Pts) with locally advanced resectable stage II‒IIIB NSCLC

Annals of Oncology(2022)10.1016/j.annonc.2022.07.1096

N/A

0DataRank · unranked

5 citations

A.W. Kim, Enriqueta Felip, Catherine A. Shu, Andrea Ferris, M. Frueh +8 more